Skip to Main Content

Paper Details

The CNIC-Polypill reduces recurrent major cardiovascular events in real-life secondary prevention patients in Spain: The NEPTUNO study.
Int J Cardiol
24
2022
ASCVD, CNIC, Equipotent, LDLc, MACE, Patients, aspirin, atherosclerotic cardiovascular disease, atorvastatin, cardiovascular, cholesterol, low-density lipoprotein cholesterol, patients, ramipril
Author NameAffiliation
Jos?? M CastellanoInstituto de Salud Carlos III, Hospital Universitario Monteprincipe, Grupo HM Hospitales
Valentin FusterInstituto de Salud Carlos III, Spain Mount Sinai Medical Center
  • 1 - 2

Datasets

Release 1.2